Cardiology Letters 2020, 29(4):259-267
Supraventricular tachycardia in idiopathic pulmonary arterial hypertension
- 1 Kardiologická klinika Lekárská fakulta a Národný ústav srdcových a cievnych chorôb, a. s., Bratislava, Centrum pre pµúcnu artériovú hypertenziu
- 2 Oddelenia arytmií a kardiostimulácie, Národný ústav srdcových a cievnych chorôb, a. s., Bratislava, Slovenská republika
Supraventricular arrhythmias in pulmonary arterial hypertension (PAH) are common and often result in severe clinical and hemodynamic deterioration. The management is complex and involves conservative and interventional approaches. We present a case of a patient with idiopathic PAH with multiple recurrent supraventricular arrhythmias. The female patient (b. 1978) was diagnosed with idiopathic PAH in 2006 and sildenafil treatment was initiated in 2007. Due to disease progression, SQ treprostinil was started in 2012 and bosentan was added in 2013. In April, 2014, she was admitted to hospital due to abrupt worsening of dyspnea and hypotension. Regular tachycardia with the rate of 150/min was detected and terminated by intravenous adenosine. On electrophysiology study (EPS), atrio-ventricular nodal re-entrant tachycardia (AVNRT) was confirmed and a successful slow pathway modulation by radio frequency (RF) ablation was performed. In addition, several regular and irregular atrial tachycardias other than typical atrial flutter were inducible by isoprenaline at EPS. A small dose of short-acting beta-blocker (metoprolol) was initiated and the patient was discharged from hospital in a clinically stable status and in sinus rhythm. However, she was re-admitted to hospital due to dyspnea at rest, signs of right ventricular failure, and persisting atrial tachycardia 6 weeks later. Electric cardioversion was performed and sinus rhythm was restored. Amiodarone was added. Further interventional treatment was not indicated due to high risk and low probability of success of the procedure in context of multiple foci of arrhythmia. Atrial tachycardia recurred soon and persisted. Unfortunately, the patient´s status further deteriorated in spite of treatment escalation and she was listed for lung transplant. Atrial tachycardia with adequate ventricular rate persisted in the long-term. The patient died of heart failure early after lung transplant.
Conclusion: SV arrhythmia can result in an abrupt destabilization of the patient´s status. We believe it is of the utmost importance to aim for reconstitution of the sinus rhythm using all available conservative and interventional approaches. On the other side, it is also possible that SV arrhythmia represents one of the signals of disease progression and a marker of unfavourable outcome. We therefore presume that on the occurrence of SV arrhythmia, pulmonary hypertension specific treatment escalation should be considered to minimize further PAH progression. Fig. 4, Tab. 3, Ref. 18, on-line full text (Free, PDF) www. cardiologyletters.sk
Keywords: supraventricular arrhythmias; idiopathic pulmonary arterial hypertension; tachycardia; dyspnea
Published: April 1, 2020 Show citation
References
- Humbert M, Guignabert C, Bonnet S, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J 2019;53(1) pii: 1801887.
Go to original source... - Vizza CD, Pezzuto B, Badagliacca R, et al. Mode of death in patients with pulmonary arterial hypertension. J Heart Lung Transplant 2013;32:S17-S18.
Go to original source... - D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-349.
Go to original source... - Galiè N, Channick RN, Frantz RP, et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J 2019;53(1). pii: 1801889.
Go to original source... - Hoeper MM, Kramer T, Pan Z, et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J. 2017;50(2). pii: 1700740
Go to original source... - Middleton JT, Maulik A, Lewis R, et al. Arrhythmic burden and outcomes in pulmonary arterial hypertension. Front. Med 2019;6:169.
Go to original source... - Mercurio V, Peloquin G, Bourji KI, et al. Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact. Pulmonary Circulation 2018;8:1-8.
Go to original source... - Tongers J, Schwerdtfeger B, Klein G, et al. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension Am Heart J 2007;53:127232.
Go to original source... - Ruiz-Cano MJ, Gonzalez-Mansilla A, Escribano P, et al. Clinical implications of supraventricular arrhythmias in patients with severe pulmonary arterial hypertension. Int J Cardiol 2011;146:105-106.
Go to original source... - Mahtani, AU, Nair, DG. Supraventricular tachycardia. Medical Clinics of North America 2019;103:863-879.
Go to original source... - Wanamaker B, Cascino T, McLaughlin V, et al. Atrial arrhythmias in pulmonary hypertension: pathogenesis, prognosis and management. Arrhythmia & Electrophysiology Review 2018;7:43-48.
Go to original source... - Zhang YQ, Zhang FL, Wang WW, et al. The correlation of pulmonary arterial hypertension with late recurrence of paroxysmal atrial fibrillation after catheter ablation. J Thoracic Dis 2018;10:2789-2794.
Go to original source... - Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. Eur Heart J 2020;41:655-720.
Go to original source... - Provencher S, Herve P, Jais X, et al. Deleterious effects of betablockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension. Gastroenterology 2006;130:120-126.
Go to original source... - ThenappanT, Roy SS, DuvalS, et al. β-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension. A propensity score analysis. Circ Heart Fail 2014;7:903-910.
Go to original source... - Olsson KM, Nickel NP, Tongers J, et al. Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol 2013;167:2300-2305.
Go to original source... - Bandorski D, Bogossian H, Ghofrani A, et al. Tachycardia and pulmonary arterial hypertension. Herzschrittmacherther Elektrophysiol. 2020;31:33-38.
Go to original source... - Galiè N, Humbert M, Vachiéry JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016;37:67-119.
Go to original source...

